Results 11 to 20 of about 928 (118)

Diabetic eye screening in people with diabetes undergoing haemodialysis: A systematic review and meta-analysis. [PDF]

Diabet Med
Abstract Aim People with diabetes receiving haemodialysis are at increased risk of diabetic retinopathy (DR) and other ocular complications. Despite this heightened vulnerability, evidence on the prevalence of such conditions in this population is limited.
Habte-Asres HH, Hailu F, Forbes A, Wheeler DC, Peto T.   +4 more
europepmc   +2 more sources

Efficacy and safety of brolucizumab in age‐related macular degeneration: A systematic review of real‐world studies

Acta Ophthalmologica, Volume 101, Issue 2, Page 123-139, March 2023., 2023
Abstract Intravitreally injected anti‐vascular endothelial growth factor (anti‐VEGF) agents are first‐line treatment for neovascular age‐related macular degeneration (nAMD). Phase 3 trials demonstrated non‐inferiority of anti‐VEGF therapy with brolucizumab compared with aflibercept in best corrected visual acuity (BCVA) gains, with superior anatomical ...
Caroline R. Baumal, Torben Lykke Sørensen, Helene Karcher, Rita L. Freitas, Anja Becher, Sébastien Balez, Andreas Clemens, Michael Singer, Laurent Kodjikian   +8 more
wiley   +1 more source

Ophthalmic imaging in diabetic retinopathy: A review

Clinical &Experimental Ophthalmology, Volume 50, Issue 9, Page 1082-1096, December 2022., 2022
Abstract Retinal imaging has been a key tool in the diagnosis, evaluation, management and documentation of diabetic retinopathy (DR) and diabetic macular oedema (DMO) for many decades. Imaging technologies have rapidly evolved over the last few decades, yielding images with higher resolution and contrast with less time, effort and invasiveness.
Onnisa Nanegrungsunk, Direk Patikulsila, Srinivas R. Sadda   +2 more
wiley   +1 more source

Interest of Widefield‐Optical Coherence Tomography Angiography for Diagnosis and Follow‐Up of Retinal Neovascularisation in Proliferative Diabetic Retinopathy

Journal of Ophthalmology, Volume 2022, Issue 1, 2022., 2022
Aim. The primary aim was to evaluate the use of optical coherence tomography angiography (OCTA) versus fluorescein angiography (FA) for detecting and monitoring retinal neovascularization (NV) in patients with proliferative diabetic retinopathy (PDR) receiving treatment with anti‐vascular endothelial growth factor (anti‐VEGF). Methods.
Brice Nguedia Vofo, Pablo Galarza, Itay Chowers, Jaime Levy, Alessandro Meduri   +4 more
wiley   +1 more source

Current Situation and Challenges in Vitreous Substitutes

Macromolecular Bioscience, Volume 21, Issue 8, August 2021., 2021
Nowadays, there are many drawbacks associated with the different agents used in clinical practice for vitreous substitution. The development of the ideal biomaterial for vitreous substitution remains one of the most important challenges in ophthalmology.
Cristina Mondelo‐García, Enrique Bandín‐Vilar, Laura García‐Quintanilla, Ana Castro‐Balado, Eva M. del Amo, María Gil‐Martínez, María José Blanco‐Teijeiro, Miguel González‐Barcia, Irene Zarra‐Ferro, Anxo Fernández‐Ferreiro, Francisco J. Otero‐Espinar   +10 more
wiley   +1 more source

Epiretinal membrane: A review

Clinical &Experimental Ophthalmology, Volume 49, Issue 3, Page 289-308, April 2021., 2021
Abstract The prevalence of epiretinal membrane (ERM) is 7% to 11.8%, with increasing age being the most important risk factor. Although most ERM is idiopathic, common secondary causes include cataract surgery, retinal vascular disease, uveitis and retinal tears.
Adrian T. Fung, Justin Galvin, Tuan Tran
wiley   +1 more source

SD-OCT-based biomarkers in predicting treatment outcomes of macular oedema secondary to retinal vein occlusion treated with anti-VEGF therapy. [PDF]

Acta Ophthalmol
Abstract Purpose To investigate the role of spectral domain optical coherence tomography (SD‐OCT)‐based biomarkers in predicting treatment response of macular oedema (MO) secondary to retinal vein occlusion (RVO) to anti‐vascular endothelial growth factor (VEGF) therapy.
Tsang KK, Hui VWK, Pang CMK, Tang Z, Yang D, Nguyen TX, Mohamed S, Lai TYY, Cheung CY, Szeto SKH.   +9 more
europepmc   +2 more sources

YAP is essential for TGF‐β‐induced retinal fibrosis in diabetic rats via promoting the fibrogenic activity of Müller cells

Journal of Cellular and Molecular Medicine, Volume 24, Issue 21, Page 12390-12400, November 2020., 2020
Abstract The purpose of this study was to investigate whether Yes‐associated protein (YAP) activation and proliferation of retinal Müller cells play a role in the development of TGF‐β‐induced retinal fibrosis. We studied the effects of YAP activation on retinal fibrosis in diabetic rats and human retinal Müller cells (hMCs) in vitro.
Wei Zhang, Yichun Kong
wiley   +1 more source

Socioeconomic impact of simultaneous bilateral rhegmatogenous retinal detachment: A single center analysis

Journal of Clinical Ophthalmology and Research, 2017
Purpose: To evaluate the reasons for poor visual outcome and the socioeconomic impact of the consequent blindness in patients with simultaneous bilateral rhegmatogenous retinal detachment (SRD).
Kalpana Badami Nagaraj, Roopashree Kamisetty   +1 more
doaj   +1 more source

"PRIMARY VITRECTOMY VERSUS SCLERAL BUCKLING IN PATIENTS WITH RETINAL DETACHMENT AFTER CATARACT SURGERY" [PDF]

Acta Medica Iranica, 2004
The purpose of this study was to compare the anatomic and visual outcome of primary vitrectomy with scleral buckling in patients with retinal detachment following cataract surgery.
"H. Faghihi, A Lashay, H. Ghazi, A. Tabatabaee, MR. Mansouri, A. Javadian, R. Karkhaneh, M. Riazi, A. Mirshahi, Z. Alami, M. Movasat, MS. Farahvash, A. Amini, H. Shams M. Nili"   +13 more
doaj   +2 more sources